← Back to search
THE UNIVERSITY OF QUEENSLAND
ST LUCIA, 4072
UnclaimedClaim this profile (free)
Prime contracting experience
5 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Defense Defense Health Agency | IMPROVING PERFORMANCE OF THE SLEEP DEPRIVED BRAIN RESEARCH AND DEVELOPMENT EFFORT, BROAD AGENCY ANNOUNCEMENT PROPOSAL SO220050. | — | $672,924 | Jul 14, 2026 | Aug 28, 2024 – Aug 27, 2027 |
| Prime | Department of Defense Department of the Army | ER20-1156 FY20 SERDP FUNDS, NEW START, T | — | $1,025,640 | Jul 3, 2024 | Aug 3, 2020 – Aug 2, 2025 |
| Prime | Department of Health and Human Services Food and Drug Administration | CONDUCT THE BLING III PK/PD SUB-STUDY, WHICH IS A PROSPECTIVE, OBSERVATIONAL, MULTINATIONAL SUB-STUDY WITHIN THE PARENT BLING III RCT. | — | $300,851 | Mar 18, 2024 | Sep 24, 2021 – Oct 29, 2023 |
| Prime | Department of Defense Department of the Navy | LMR EV11 MYSTICETE AUDIOGRAM | — | $780,933 | Jan 17, 2024 | Sep 16, 2019 – Dec 31, 2024 |
| Prime | Department of Defense Department of the Air Force | ARMY RESEARCH AND DEVELOPMENT - RESILIENT LEARNING-BASED DEFENSE IN ADVERSARIAL UNCERTAIN ENVIRONMENTS | — | $421,074 | Jul 27, 2022 | Sep 15, 2020 – Sep 14, 2023 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Subcontracting experience
7 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Subcontractor | Department of Defense | LEACHING OF PFASS FROM AFFF-IMPACTED CONSTRUCTION MATERIALS 402624-402627-7203 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541715 Parent award performance state: CO Parent award description: SERDP PROJECT ER23-3724 "LEACHING OF PFASS FROM AFFF-IMPACTED CONSTRUCTION MATERIALS" View parent award on USAspending | — | $75,000 | Apr 27, 2026 | — – — |
| Subcontractor | Department of Defense | LEACHING OF PFASS FROM AFFF-IMPACTED CONSTRUCTION MATERIALS 402624-402627-7203 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541715 Parent award performance state: CO Parent award description: SERDP PROJECT ER23-3724 "LEACHING OF PFASS FROM AFFF-IMPACTED CONSTRUCTION MATERIALS" View parent award on USAspending | — | $40,000 | Oct 7, 2025 | — – — |
| Subcontractor | Department of Defense | LEACHING OF PFASS FROM AFFF-IMPACTED CONSTRUCTION MATERIALS 402624-402627-7203 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541715 Parent award performance state: CO Parent award description: SERDP ER20-3060: FOLLOW-ON TO ER 18-1501 View parent award on USAspending | — | $40,000 | Apr 10, 2025 | — – — |
| Subcontractor | Department of Defense | TO PROVIDE LABORATORY TESTING AND CONSULTING SERVICES. US3460015799R1 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541715 Parent award performance state: CO Parent award description: ESTCP PROJECT ER22-7313 "MANAGEMENT AND MITIGATION OF PFAS LEACHING FROM CONCRETE" View parent award on USAspending | — | $168,000 | Jun 13, 2024 | — – — |
| Subcontractor | Department of Defense | LEACHING OF PFASS FROM AFFF-IMPACTED CONSTRUCTION MATERIALS 402624-402627-7203 Parent award context Parent award agency: Department of Defense · Department of the Army Parent award NAICS: 541715 Parent award performance state: CO Parent award description: SERDP PROJECT ER23-3724 "LEACHING OF PFASS FROM AFFF-IMPACTED CONSTRUCTION MATERIALS" View parent award on USAspending | — | $40,000 | Jan 9, 2024 | — – — |
| Subcontractor | Department of Health and Human Services | THE UNIVERSITY OF QUEENSLAND (UQ) IN PARTNERSHIP WITH CARB-X, WILL DEVELOP NEW ANTIBIOTICS TO TREAT GRAM-NEGATIVE PATHOGENS THAT ARE DESIGNATED AS SERIOUS PUBLIC HEALTH THREATS BY THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) AND THE WORLD HEALTH ORGANIZATION (WHO). UQ€„¢S APPROACH IS TO ADVANCE A NOVEL ANTIBIOTIC CLASS CALLED OCTAPEPTIN-X (OPX), WHICH IS A LIPOPEPTIDE WITH NATURAL PRODUCT ORIGINS.
OPX EXHIBITS BROAD SPECTUM ACTIVITY AGAINST A RANGE OF GRAM-NEGATIVE BACTERIA, INCLUDING THOSE THAT ARE RESISTANT TO POLYMYXIN. THE NOVELTY AND UTILITY OF OPX IS EXEMPLIFIED BY: (I) INTRINSIC ACTIVITY AGAINST POLYMYXIN-RESISTANT PATHOGENS; (II) A LOW PROPENSITY TO INDUCE RESISTANCE, OCCURING BY UNIQUE MECHANISMS NOT SHARED BY POLYMYXIN; (III) REDUCED NEPHROTOXIC POTENTIAL.
POLYMYXIN BASED ANTIBIOTICS ARE TOXIC, SUFFERING FROM A NARROW THERAPEUTIC WINDOW AND HIGH INCIDENCES OF KIDNEY TOXICITY. NEXT-GENERATION POLYMYXIN CANDIDATES CURRENTLY IN DEVELOPMENT OFFER PROMISE OF REDUCED TOXICITY, BUT REMAIN INEFFECTIVE AGAINST POLYMYXIN RESISTANT ISOLATES. THE LACK OF CROSS-RESISTANCE BETWEEN OPX AND POLYMYXIN THEREFORE MAKES OPX A POTENTIAL CHOICE TO TREAT PATIENTS SUFFERING FROM INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA RESISTANT TO POLYMYXIN, AND/OR OTHER ANTIBIOTIC CLASSES COMPROMISED BY CONTEMPORARY MULTI-DRUG RESISTANCE.
THUS, UQ€„¢S COMMITMENT IS TO DEVELOP OPX AS A SAFE AND NOVEL TREATMENT PARADIGM FOR DRUG-RESISTANT INFECTIONS DEEMED UNTREATABLE BY CONVENTIONAL THERAPIES. TARGET INDICATIONS MAY INCLUDE MAY INCLUDE URINARY TRACT INFECTIONS (CUTIS), ACUTE PYELONEPHRITIS, COMPLICATED INTRA-ABDOMINAL INFECTIONS (CIAIS), OR COMMUNITY/HOSPITAL/VENTILATOR-ACQUIRED PNEUMONIA (CAP/HAP/VAP).
WITH CARB-X SUPPORT, UQ WILL TAKE THE APPROACH OF MITIGATING TOXICITY RISKS VERY EARLY IN THE PROGRAM BY PRIMING ITS DISCOVERY PATHWAY WITH DETAILED ANIMAL MODELS DESIGNED TO IDENTIFY EVIDENCE OF KIDNEY TOXICITY WITHIN ITS LEAD COMPOUND PORTFOLIO. THE FIRST STAGE OF THE PROGRAM WILL CULMINATE IN THE NOMINATION OF A MOLECULE SUITABLE FOR PROGRESSION INTO DETAILED MICROBIOLOGICAL, SAFETY AND EFFICACY TESTING TOWARD CANDIDATE SELECTION (2021). SUBSEQUENT STAGES OF THE PROGRAM WILL ADDRESS ASPECTS OF CHEMISTRY MANUFACTURING AND CONTROLS (CMC; 2022) FOLLOWED BY GLP TOXICOLOGY STUDIES TOWARD INVESTIGATIONAL NEW DRUG (IND) SUBMISSION (2023), AND LASTLY FIRST IN HUMAN PHASE 1 CLINICAL TRIALS (2024).
INTELLECTUAL PROPERTY FOR OPX IS SOLELY OWNED BY UQ. 4500004567 Parent award context Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response Parent award NAICS: 541714 Parent award performance state: MA Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA View parent award on USAspending | — | $32,977 | Feb 21, 2023 | — – — |
| Subcontractor | Department of Health and Human Services | THE OBJECTIVE OF THE PROJECT IS TO DETERMINE AND DESCRIBE THE "GLOBAL EXPERIENCE WITH AUTOMATION" FOR THE PURPOSES OF IDENTIFYING THE GAPS IN THE BODY OF KNOWLEDGE RELATED TO SAFETY HEALTH IMPACTS OF THE AUTOMATION TRANSITION AND TO INFORM FUTURE PRIORITIZED AND TARGETED RESEARCH IN MINING IN THE COMING 5 YEARS. THROUGH A LITERATURE REVIEW, AN INCIDENT DATA COLLECTION EFFORT, A SERIES OF SITE VISITS, SEVERAL WORLD-WIDE CASE STUDIES, AND COLLATION OF BEST PRACTICES AND LESSONS LEARNED; WE WILL DEVELOP AND THEN DISSEMINATE A BETTER UNDERSTANDING OF THE STATE OF THE MINING INDUSTRY RELATED TO PROTECTING THE SAFETY AND HEALTH OF THEIR WORKERS WHO ENGAGE WITH TECHNOLOGY AND AUTONOMOUS SYSTEMS AS THESE SYSTEMS ARE BEING RAPIDLY DEPLOYED, USED AND MAINTAINED. AWD00002910-1 Parent award context Parent award agency: Department of Health and Human Services · Centers for Disease Control and Prevention Parent award NAICS: 611310 Parent award performance state: PA Parent award description: AUTOMATION EXPERIENCE WITH A GLOBAL PERSPECTIVE View parent award on USAspending | — | $250,000 | May 13, 2022 | — – — |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of DefenseGov-sourced
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.